rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2005-10-5
|
pubmed:abstractText |
Therapeutic phlebotomy for hereditary hemochromatosis is relatively safe and presumably efficacious when offered before cirrhosis develops, so screening primary care patients is of substantial interest.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1539-3704
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
4
|
pubmed:volume |
143
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
522-36
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:16204165-Adult,
pubmed-meshheading:16204165-Evidence-Based Medicine,
pubmed-meshheading:16204165-Ferritins,
pubmed-meshheading:16204165-Genetic Testing,
pubmed-meshheading:16204165-Hematologic Tests,
pubmed-meshheading:16204165-Hemochromatosis,
pubmed-meshheading:16204165-Humans,
pubmed-meshheading:16204165-Phlebotomy,
pubmed-meshheading:16204165-Prevalence,
pubmed-meshheading:16204165-Primary Health Care,
pubmed-meshheading:16204165-Risk Assessment,
pubmed-meshheading:16204165-Sensitivity and Specificity,
pubmed-meshheading:16204165-Transferrin
|
pubmed:year |
2005
|
pubmed:articleTitle |
Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: systematic review for the American College of Physicians.
|
pubmed:affiliation |
Loyola University Medical Center, Maywood, Illinois, USA. brian.schmitt2@med.va.gov
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|